Quick10K

⚲

Piper Jaffray

Filings

10-K	2020-12-31	Filed 2021-02-25
10-Q	2020-09-30	Filed 2020-11-05
10-Q	2020-06-30	Filed 2020-08-06
10-Q	2020-03-31	Filed 2020-05-08
10-K	2019-12-31	Filed 2020-02-28
10-Q	2019-09-30	Filed 2019-11-07
10-Q	2019-06-30	Filed 2019-08-02
10-Q	2019-03-31	Filed 2019-05-08
10-K	2018-12-31	Filed 2019-02-26
10-Q	2018-09-30	Filed 2018-11-05
10-Q	2018-06-30	Filed 2018-08-08
10-Q	2018-03-31	Filed 2018-05-04
10-K	2017-12-31	Filed 2018-02-26
10-Q	2017-09-30	Filed 2017-11-08
10-Q	2017-06-30	Filed 2017-08-04
10-Q	2017-03-31	Filed 2017-05-09
10-K	2016-12-31	Filed 2017-02-24
10-Q	2016-09-30	Filed 2016-10-28
10-Q	2016-06-30	Filed 2016-08-05
10-Q	2016-03-31	Filed 2016-05-04
10-K	2015-12-31	Filed 2016-02-25
10-Q	2015-09-30	Filed 2015-10-30
10-Q	2015-06-30	Filed 2015-08-05
10-Q	2015-03-31	Filed 2015-05-01
10-K	2014-12-31	Filed 2015-02-26
10-Q	2014-09-30	Filed 2014-11-06
10-Q	2014-06-30	Filed 2014-07-30
10-Q	2014-03-31	Filed 2014-05-01
10-K	2013-12-31	Filed 2014-02-28
10-Q	2013-09-30	Filed 2013-10-31
10-Q	2013-06-30	Filed 2013-07-31
10-Q	2013-03-31	Filed 2013-05-03
10-K	2012-12-31	Filed 2013-02-27
10-Q	2012-09-30	Filed 2012-11-02
10-Q	2012-06-30	Filed 2012-08-02
10-Q	2012-03-31	Filed 2012-05-03
10-K	2011-12-31	Filed 2012-02-27
10-Q	2011-09-30	Filed 2011-11-03
10-Q	2011-06-30	Filed 2011-08-04
10-Q	2011-03-31	Filed 2011-05-05
10-K	2010-12-31	Filed 2011-02-28
10-Q	2010-09-30	Filed 2010-11-03
10-Q	2010-06-30	Filed 2010-08-04
10-Q	2010-03-31	Filed 2010-05-07
10-K	2009-12-31	Filed 2010-02-26

Reports

8-K	2020-10-30
8-K	2020-07-31
8-K	2020-05-15
8-K	2020-05-01
8-K	2020-04-03
8-K	2020-02-21
8-K	2020-01-31
8-K	2020-01-03
8-K	2019-12-20
8-K	2019-12-13
8-K	2019-10-30
8-K	2019-10-15
8-K	2019-09-16
8-K	2019-07-26
8-K	2019-07-09
8-K	2019-07-09
8-K	2019-05-29
8-K	2019-05-17
8-K	2019-04-26
8-K	2019-02-25
8-K	2019-02-01
8-K	2018-10-26
8-K	2018-09-12
8-K	2018-07-27
8-K	2018-05-17
8-K	2018-04-27
8-K	2018-02-06
8-K	2018-02-01
8-K	2018-01-01

Piper Jaffray Financials

PJC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
CNB Financial (CCNE)	450		5.1	1%	3,541	3,244	0	0	39	78	398
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
Timberline Resources (TLR)
Almost Never Films (HLWD)
1st United Bancorp (FUBC)
Manchester United (MANU)				0%	1,497		0	0	0	0	-308
SQL Technologies (SQFL)		18%	1.5	0%	7	30	9	2	0	2	3
2-Track Global (TTG)
GB Sciences (GBLX)	23	-23%	-1.8	-56%	30	16	4	-1	-17	-13	23
Nemaura Medical (NMRD)	158		-32.0	-182%	3	3	0	0	-5	-5	156
Monroe Bank and Trust (MBTF)	232		-6.6	1%	1,327	1,191	0	0	10	16	-107
Solis Tek (SLTK)	44	51%	-25.8	-163%	1	7	2	1	-2	-2	44
Cumulus Media (CMLS)			-94.7	-0%			0	0	0	-11	1,004
Cyclo Therapeutics, Inc. (CYTHW)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2010-06-30	2010-09-30	2010-12-31	2011-03-31	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	47	39	51	43	70	43	86	55	40	42	105	23	69	14	124	35	55	15	16	9	14	44	190	49	172	51	41	19	26	41	34	28	26	69	50	18	23	24
Accounts Receivable
Inventory
PP&E	16	20	21	22	22	23	81	22	20	17	76	14	13	15	78	15	16	17	65	19	19	19	71	21	22	23	84	25	25	24	81	25	27	31	93	32	31	31
Assets	2,004	2,061	2,034	1,962	2,222	2,135	1,656	1,889	1,999	1,961	2,088	2,330	2,276	2,493	2,318	2,317	2,426	2,601	2,624	2,917	2,410	2,299	2,139	2,178	2,121	2,211	2,126	2,113	1,931	1,740	2,025	1,577	1,515	1,493	1,345	1,170	1,206	1,344
Accounts Payable
Long-Term Debt			125	122	120	118	115	109	89	83	0
Liabilities	1,187	1,256	1,220	1,128	1,359	1,265	905	1,131	1,257	1,190	1,298	1,468	1,408	1,636	1,436	1,400	1,496	1,655	1,654	1,930	1,457	1,466	1,306	1,325	1,294	1,372	1,309	1,291	1,097	953	1,283	842	777	746	615	456	480	582
Stockholders' Equity	817	805	813	834	842	839	718	722	703	725	733	752	730	707	735	767	788	805	820	831	790	795	784	805	775	784	759	778	790	738	693	688	686	700	677	661	658	697


Income Statement ($MM)	2010-06-30	2010-09-30	2010-12-31	2011-03-31	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	136	129	185	133	152	107	106	124	129	140	146	118	109	139	194	174	176	166	157	168	170	155	203	160	176	206	228	205	204	245	241	174	179	221	227	194	175	203
Cost of Revenue
Gross Profit
R&D
SG&A	6	6	6	6	7	6	6	5	6	4	5	5	6	5	5	6	8	7
Tax	4	7	14	19	6	4	-3	8	-0	9	-3	6	2	3	10	20	10	23	8	16	10	2	7	20	2	7	-26	8	5	-31	57	12	2	7	14	7	1	0
Net Income	7	7	9	7	11	-3	-116	4	13	20	12	12	2	8	31	23	31	17	14	22	17	5	15	3	5	12	-33	23	15	-50	-46	11	6	22	18	19	19	43


Cash Flow ($MM)	2010-06-30	2010-09-30	2010-12-31	2011-03-31	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		21	-34	26	-109	-37	195	-204	-82	86	-12	-184	60	-140	310	-45	151	-74	-82	-175	175	291	89	-74	136	-18	6	140	33	271	-212	146	146	68		29	16	-26
Cash Investing		-6	-8	-2	-2	-2	-1	-2	1	1	-2	-0	-1	-27	-2	-1	-2	-3	-0	-2	-0	-9	-5	-72	-4	-3	-5	-2	-1	-1	-4	-2	-5	-6		-1	-2	32
Cash Financing		-24	53	-31	138	13	-187	175	66	-85	79	101	-13	112	-198	-44	-129	37	84	171	-170	-251	61	5	-8	-99	-10	-161	-25	-255	208	-152	-142	-19		-60	-8	-5